Lnc. Martin et al., PARATHYROID-GLANDS IN UREMIC PATIENTS WITH REFRACTORY HYPERPARATHYROIDISM - HISTOPATHOLOGY AND P53 PROTEIN EXPRESSION ANALYSIS, Histopathology, 33(1), 1998, pp. 46-51
Aims: Refractory hyperparathyroidism is a state of parathyroid hyperfu
nction and hypercalcaemia in uraernic patients with previous secondary
hyperplasia. We studied histopathological features and p53 expression
in 49 parathyroid glands of uraemic patients (n=21) with refractory h
yperparathyroidism in order to investigate whether p53 abnormalities c
ould be present in parathyroid hyperplasias of chronic renal failure.
Methods and results: Nodular hyperplasia was found in 77.5% of the gla
nds (n = 38). The proportion of oxyphil cells and acinar cell arrangem
ents was higher in nodular hyperplasia than in diffuse hyperplastic gl
ands (P<0.001), Duration of renal disease and haemodialysis treatment
tended to be longer in patients with nodular hyperplasia, There was no
correlation between serum intact PTH (iPTH), calcium and hyperplasia
pattern, A trend for a higher glandular mass was found in nodular type
hyperplasia (1.88 +/- 2.13 g) than in diffuse type hyperplasia (0.87/-1.28g; P=0.06). Nuclear p53 immunoreactivity was shown in 55% of the
hyperplastic glands, whereas it was not detected in 12 normal parathy
roid glands used as controls. p53 staining was present in c, 82% of th
e diffuse hyperplastic glands and in 47% of the nodular hyperplastic g
lands (P=0.08), Conclusions: Nodular type hyperplasia was the predomin
ant histopathological pattern in uraemic patients with refractory hype
rparathyroidism in our study. Nodular hyperplastic glands characterist
ically had higher percentage of oxyphil cells, acinar cell arrangement
s and mass than diffuse hyperplastic glands. A high prevalence of p53
protein expression was found in hyperplastic glands of uraemic patient
s. Our results suggest that p53 abnormalities might be involved in the
pathogenesis of parathyroid hyperplasia in chronic renal failure.